| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/29/2011 | US20110236403 Targeting pax2 for the induction of defb1-mediated tumor immunity and cancer therapy |
| 09/29/2011 | US20110236400 Tetrahydropyranochromene gamma secretase inhibitors |
| 09/29/2011 | US20110236397 Limited proteolysis of cd2ap and progression of renal disease |
| 09/29/2011 | US20110236396 Methods and compositions for diagnosing and treating a colorectal adenocarcinoma |
| 09/29/2011 | US20110236395 Treatment of fibrotic eye disorders using an mmp2 inhibitor |
| 09/29/2011 | US20110236394 Methods for the regulation of the prostaglandin f synthase (pgfs) activity of akr1b1 and uses thereof |
| 09/29/2011 | US20110236393 Monoclonal antibody production in b cells and uses therof |
| 09/29/2011 | US20110236392 Composition and method for treatment of preterm labor |
| 09/29/2011 | US20110236382 Immunosuppressive combination and its use in the treatment or prophylaxis of insulin-producing cell graft rejection |
| 09/29/2011 | US20110236381 Inhibition of inter-alpha trypsin inhibitor for the treatment of airway disease |
| 09/29/2011 | US20110236371 Compositions And Methods For The Treatment Of Neurologic And Psychiatric Conditions |
| 09/29/2011 | US20110236370 Genetic Alterations on Chromosomes 21q, 6q and 15q and Methods of Use Thereof for the Diagnosis and Treatment of Type I Diabetes |
| 09/29/2011 | US20110236365 Method for protecting and treating at least one muscarinic receptor from dysfunction resulting from free radical damage |
| 09/29/2011 | US20110236364 Compositions containing non-polar compounds |
| 09/29/2011 | US20110236358 Composition comprising isoflavones |
| 09/29/2011 | US20110236349 Use of Epidermal Growth Factor Inhibitors in the Treatment of Viral Infection |
| 09/29/2011 | US20110236348 Modulators of toll-like receptor 7 |
| 09/29/2011 | US20110236344 Synthetic mimics of mammalian cell surface receptors: method and compositions |
| 09/29/2011 | US20110236340 Crosslinked cation exchange polymers, compositions and use in treating hyperkalemia |
| 09/29/2011 | US20110236330 Skin Whitening |
| 09/29/2011 | US20110236327 Continuous Moisturization Compositions |
| 09/29/2011 | US20110236326 Skin Whitener |
| 09/29/2011 | US20110236325 Methods to treat or prevent a skin condition using a nell1 peptide |
| 09/29/2011 | US20110236322 Oral ph and buffering capacity modifiers |
| 09/29/2011 | US20110236317 Tetrahydrotriazine compounds for treating diseases associated with ampk acitivity |
| 09/29/2011 | US20110236314 Method of detection and diagnosis of oral and nasopharyngeal cancers |
| 09/29/2011 | US20110236306 Compositions and methods for the removal of biofilms |
| 09/29/2011 | US20110236305 Methods for protecting and regenerating bone marrow using cxcr3 agonists and antagonists |
| 09/29/2011 | DE19724456B4 Medizinische Mischungszusammensetzung mit lang anhaltender Arzneimittelabgabemöglichkeit Medical mixture composition with sustained drug delivery option |
| 09/29/2011 | DE112009001010T5 Biologisches Verfahren zur in-vivo-Detektion von Molekülen, die die Zellmigration beeinflussen Biological process for the in vivo detection of molecules which affect the cell migration |
| 09/29/2011 | DE102010013081A1 Antimikrobielle Öl in Wasser Emulsion Antimicrobial oil in water emulsion |
| 09/29/2011 | CA2831265A1 Composition for enhancing athletic performance |
| 09/29/2011 | CA2794559A1 Solid forms of (r)-1(2,2-difluorobenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide |
| 09/29/2011 | CA2794540A1 Methods and compositions for weight loss |
| 09/29/2011 | CA2794503A1 Aerosol foams comprising clindamycin phosphate |
| 09/29/2011 | CA2794481A1 Carvacrol and/or thymol or composition thereof for preventing of infection or infestation of an ectoparasitic copepod in fish |
| 09/29/2011 | CA2794480A1 Carvacrol/thymol composition for the treatment of salmonid rickettsial septicemia and infectious salmon anemia |
| 09/29/2011 | CA2794307A1 Modified polymers for delivery of polynucleotides, method of manufacture, and methods of use thereof |
| 09/29/2011 | CA2794266A1 Compositions and methods for glucose transport inhibition |
| 09/29/2011 | CA2794251A1 Emulsions useful in beverages |
| 09/29/2011 | CA2794237A1 Novel composition for treatment of essential thrombocythemia |
| 09/29/2011 | CA2794221A1 Double-layer pharmaceutical formulations containing opioid agonists and antagonists |
| 09/29/2011 | CA2794211A1 Benzonaphthyridinamines as autotaxin inhibitors |
| 09/29/2011 | CA2794199A1 Aptamer for ngf and use thereof |
| 09/29/2011 | CA2794187A1 Rna interference in ocular indications |
| 09/29/2011 | CA2794171A1 Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances |
| 09/29/2011 | CA2794153A1 Chemical compounds |
| 09/29/2011 | CA2794145A1 Analogues for the treatment or prevention of flavivirus infections |
| 09/29/2011 | CA2794142A1 Materials and methods related to modulation of mismatch repair and genomic stability by mir-155 |
| 09/29/2011 | CA2794097A1 Use of anatabine to treat inflammation and methods of synthesizing anatabine |
| 09/29/2011 | CA2794086A1 Heterocyclic compounds useful for kinase inhibition |
| 09/29/2011 | CA2794006A1 (20s)-2-methylene-19-nor-22-dimethyl-1.alpha.,25-dihydroxyvitamin d3 and (20r)-2-methylene-19-nor-22-dimethyl-1.alpha.,25-hydroxyvitamin d3 |
| 09/29/2011 | CA2794004A1 Imaging agents for detecting neurological disorders |
| 09/29/2011 | CA2794003A1 Novel spiro imidazolones as glucagon receptor antagonists, compositions, and methods for their use |
| 09/29/2011 | CA2793999A1 Sarms and method of use thereof |
| 09/29/2011 | CA2793973A1 Pharmaceutical compositions of carvedilol salts and process for preparation thereof |
| 09/29/2011 | CA2793949A1 Novel spiro imidazolone derivatives as glucagon receptor antagonists, compositions, and methods for their use |
| 09/29/2011 | CA2793884A1 Crystalline forms of a macrolide, and uses therefor |
| 09/29/2011 | CA2793876A1 Antimicrobial compositions |
| 09/29/2011 | CA2793725A1 Carboxamide bioisosteres of opiates |
| 09/29/2011 | CA2793712A1 Compositions and methods for non-toxic delivery of antiprogestins |
| 09/29/2011 | CA2793643A1 Compounds targeting the vegf and/or hif pathway such as sorafenib or vatalanib for use in the treatment of otitis media |
| 09/29/2011 | CA2793578A1 Endoparasiticidal compositions |
| 09/29/2011 | CA2793536A1 Methods of treatment of hepatocellular carcinoma |
| 09/29/2011 | CA2793533A1 Polymorphic forms of st-246 and methods of preparation |
| 09/29/2011 | CA2793153A1 Fe(iii) complex compounds for the treatment and prophylaxis of iron deficiency symptoms and iron deficiency anemias |
| 09/29/2011 | CA2793085A1 Anti-allergic agent |
| 09/29/2011 | CA2792938A1 Compounds (cystein based lipopeptides) and compositions as tlr2 agonists used for treating infections, inflammations, respiratory diseases etc. |
| 09/29/2011 | CA2792913A1 Improved stable aqueous formulation of (e)-4-carboxystyryl-4-chlorobenzyl sulfone |
| 09/29/2011 | CA2792883A1 Compositions and methods for prevention and treatment of wounds |
| 09/29/2011 | CA2792649A1 Improved methods and compositions for safe and effective treatment of telangiectasia |
| 09/29/2011 | CA2792646A1 Improved uses and compositions for safe and effective treatment of erythema |
| 09/29/2011 | CA2792339A1 Substituted imidazo[1,2-b]pyridazine derivatives, pharmaceutical compositions, and methods of use as beta-secretase inhibitors |
| 09/29/2011 | CA2792276A1 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
| 09/29/2011 | CA2792266A1 Method of reducing intraocular pressure in humans using n6-cyclopentyladenosine (cpa), cpa derivatives or prodrugs thereof |
| 09/29/2011 | CA2792265A1 Adenosine compounds and their use thereof |
| 09/29/2011 | CA2792136A1 Reverse micelle system comprising metal ions and use thereof |
| 09/29/2011 | CA2790914A1 Pharmaceutical composition comprising dipeptidyl peptibase-iv inhibitor for the prevention or the treatment of non-alcoholic fatty liver disease and the method for prevention or treatment of non-alcoholic fatty liver disease using the same |
| 09/29/2011 | CA2790139A1 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators |
| 09/29/2011 | CA2790087A1 Viral inhibitor compositions for in vivo therapeutic use comprising a combination of (-)-carvone, (+)-carvone, geraniol and a further essential oil component |
| 09/29/2011 | CA2789900A1 Pharmaceutical composition comprising a pyrimidineone derivative |
| 09/29/2011 | CA2789778A1 Cyclopentyl - and cycloheptylpyrazoles as fxr modulators |
| 09/29/2011 | CA2789200A1 Pharmaceutically active disubstituted triazine derivatives |
| 09/29/2011 | CA2786900A1 Pyrrolopyrazine kinase inhibitors |
| 09/29/2011 | CA2786402A1 Pyrrolopyrazine derivatives and their use as jak and syk inhibitors |
| 09/29/2011 | CA2786213A1 N-(imidazopyrimidin-7-yl)-heteroarylamide derivatives and their use as pde10a inhibitors |
| 09/29/2011 | CA2785629A1 Compositions for topical administration |
| 09/28/2011 | EP2369517A2 Methods for the identification of microrna and their applications in research and human health |
| 09/28/2011 | EP2368989A1 Oligoribonucleotide or peptide nucleic acid capable of inhibiting activity of hepatitis c virus |
| 09/28/2011 | EP2368988A1 Modulation of Glucocorticoid Receptor Expression |
| 09/28/2011 | EP2368910A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 09/28/2011 | EP2368901A1 Peptidomimetic protease inhibitors |
| 09/28/2011 | EP2368890A1 Hepatitis C virus inhibitors |
| 09/28/2011 | EP2368889A1 Inhibitors of tyrosine kinases |
| 09/28/2011 | EP2368887A1 1, 2, 3-triazole derivatives for use as stearoyl-COA desaturase inhibitors |
| 09/28/2011 | EP2368886A1 Novel compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (ROR gamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune desease |
| 09/28/2011 | EP2368885A1 Derivatives of phenazine useful to treat cancer |
| 09/28/2011 | EP2368882A1 Anti-infective pyrimidines and uses thereof |
| 09/28/2011 | EP2368881A1 Heteropyrazole analogs acting on cannabinoid receptors |
| 09/28/2011 | EP2368880A1 6-(Heterocycle-Substituted Benzyl)-4-Oxoquinoline Compound and Use of the Same as HIV Integrase Inhibitor |